Chief, Benign Hematology Baylor College of Medicine
Hematology
Dr. Mark Udden, MD
|
|
Give Review
Mark Udden practices Hematology. He went to Baylor College of Medicine. He over the years received 2 awards: "Top Doctors:SE Texas" and "CMS Meaningful Use Stage 1 Certification". Doctor Mark Udden, MD is a published physician. He published 52 publications, including: 'Successful hydroxyurea treatment of a patient with SD hemoglobinopathy.' Mark Udden, MD is registered with Medicare and accepts Medicare payments.
Publications
- Treatment of refractory thrombotic thrombocytopenic purpura With N-acetylcysteine: a case report.
- Internal medicine clerkship characteristics Associated with enhanced student examination performance.
- Pappenheimer bodies: a brief historical review.
- Plasmablastic Lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.
- Does being a clerkship director benefit academic career advancement: results of a national survey.
- HIV-related Hodgkin's disease With central nervous system involvement and association With Epstein-Barr virus.
- In vitro sub-hemolytic effects of butoxyacetic acid on human and rat erythrocytes.
- Sickle erythrocytes increase prostacyclin and endothelin-1 production by cultured human endothelial cells under flow conditions.
- Regression of a plasmablastic lymphoma in a patient With HIV on highly active antiretroviral therapy.
- Carboxyhemoglobin levels in patients with sickle-cell Anemia: relationship to hemolytic and vasoocclusive severity.
- Use of a ''passport'' documents the proficiency of physical examination skills of medical students during the core clerkship in medicine.
- The responsibilities and activities of internal medicine clerkship directors.
- Calmodulin binding to the C-terminus of the small-conductance Ca2+-activated K+ channel hSK1 is affected by alternative splicing.
- Rat erythrocyte morphological changes after gavage dosing With 2-butoxyethanol: a comparison With the in vitro effects of butoxyacetic acid on rat and human erythrocytes.
- Perfusion With sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells.
- Donor cell Leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.
- Successful hydroxyurea treatment of a patient With SD hemoglobinopathy.
- Aplastic Anemia in eosinophilic fasciitis: responses to immunosuppression and marrow transplantation.
- Pure red cell aplasia Associated with hepatitis C infection.
- Autoimmune hemolytic Anemia, primary adrenal insufficiency, and the antiphospholipid syndrome.
- Neocytolysis: physiological down-regulator of red-Cell mass.
- Destruction of newly released red blood Cells in space flight.
- Case reports: delayed hemolytic transfusion reaction in sickle cell Disease.
- Control of red blood Cell mass in spaceflight.
- Adhesion of Sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro.
- Unusually large von Willebrand factor multimers preferentially promote young Sickle and nonSickle erythrocyte adhesion to endothelial cells.
- Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: II. Resistance in red blood cells from humans With potential...
- Hemolysis and deformability of erythrocytes exposed to butoxyacetic acid, a metabolite of 2-butoxyethanol: I. Sensitivity in rats and resistance in normal humans.
- Oxygen transport in thin layers of packed Sickle erythrocytes.
- Decreased production of red blood Cells in human subjects exposed to microgravity.
- Blood volume and erythropoiesis in the rat during spaceflight.
- Flow cytometric studies of platelet responses to shear stress in whole blood.
- Problems in measurement of erythrocyte calcium.
- Reduced erythrocyte deformability Associated with calcium accumulation.
- Unusually large von Willebrand factor multimers increase adhesion of Sickle erythrocytes to human endothelial cells under controlled flow.
- Erythrocyte calcium in Chronic renal failure.
- Change in red blood cell relaxation With hydration: application to MR imaging of hemorrhage.
- Reaction order of Saccharomyces cerevisiae alpha-factor-mediated Cell cycle arrest and mating inhibition.
- Plasma prekallikrein (Fletcher factor) deficiency in a patient with chronic lymphocytic Leukemia.
- Splenic infarction, splenic sequestration, and functional hyposplenism in hemoglobin S-C Disease.
- New Abnormalities in the morphology, cell surface receptors, and electrolyte metabolism of In(Lu) erythrocytes.
- Bone marrow histiocytic hyperplasia and hemophagocytosis With pancytopenia in typhoid fever.
- Review of studies concerning the tumorigenicity of 2-butoxyethanol in B6C3F1 mice and its relevance for human risk assessment.
- Red Cell osmotic fragility studies in hemoglobin C-beta thalassemia: osmotically resistant microspherocytes.
- Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
- Effects of diethylene glycol butyl ether and butoxyethoxyacetic acid on rat and human erythrocytes.
- Butoxyacetic acid-induced hemolysis of rat red blood Cells: effect of external osmolarity and cations.
- Erythrocyte membrane sulfatide plays a crucial role in the adhesion of Sickle erythrocytes to endothelium.
- Rheological studies of erythrocyte-endothelial cell interactions in sickle cell Disease.
- Endothelial cell interactions With sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow.
- Transplantation of bone marrow: graft-vs.-host Disease.
Schools
University of Texas Southwestern Medical Center At Dallas
Baylor Affil Hosps
Baylor College Of Med
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Top Doctors:SE Texas
- CMS Meaningful Use Stage 1 Certification
Education
-
Baylor College of Medicine -
University of Texas Southwestern Medical School
Hospital
-
Baylor St. Luke's Medical Center -
Harris Health System
Drug Facts
| NPI NUMBER | 1235219577 | |
| NPPES Provider LastName | UDDEN | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 770302348 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 165.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 11.52 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235219577 |
| Last Name Of The Provider | UDDEN |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Patrick H. Archie, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Kornblau, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Donna M. Weber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie H. Rowe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel A. Escobar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Borje S. Andersson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|